Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy? (Q83153681)
Jump to navigation
Jump to search
scientific article published on 01 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy? |
scientific article published on 01 January 2012 |
Statements
Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy? (English)
Undurti N Das
1 January 2012